Specific serotonin (5-HT3) receptor antagonist. Prepn: P. Donatsch et al., DE 3322574 (1983 to Sandoz); idem et al., US 4789673 (1988). Pharmacology: B. P. Richardson et al., Nature 316, 126 (1985); F. M. Williams et al., J. Cardiovasc. Pharmacol. 7, 550 (1985). Receptor binding studies: C. Waeber et al., Neuroscience 31, 393 (1989). Clinical pharmacokinetics: V. Fischer et al., Drug Metab. Dispos. 20, 603 (1992). Series of articles on antiemetic efficacy in chemotherapy and radiotherapy: Drugs 43, Suppl. 3, 6-39 (1992). Review of pharmacology: C. Seynaeve et al., Anti-Cancer Drugs 2, 343-355 (1991); and toxicology: K. Kutz, Ann. Oncol. 4, Suppl. 3, S15-S18 (1993).
Antiemetic.
Antiemetic; Serotonin Receptor Antagonist